I notice that the great link which you found contains a compound CCT241533 which is under pre clinical development. Is this an older version of our trial compound do you know or is it a separate compound not related to SAR?
Many thanks Egatrom. I was fortunate to make some nice money back in 2010-11 on the last spike, but this is ready to outshine that, by a long way. If i do miss it their is always other companies i am still in a few. You never know if a few clients pay their bills i,ll be back.
I agree Thoth2, it can't just be a coincidence that AZN have sniffed around SAR B4 and now with Chk1 trials, the stamp of approval from CRUK, that they now say they are going to concentrate on oncology. Not a big leap of faith that they may have eyes for SAR. If they have it will be kept very much under wraps until they are all good and ready.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.